Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Recommendation of “Buy” from Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has earned an average recommendation of “Buy” from the six ratings firms that are covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $13.63.

Several equities analysts have weighed in on BIOX shares. Canaccord Genuity Group lowered their price objective on shares of Bioceres Crop Solutions from $17.00 to $12.50 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Lake Street Capital lowered their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Roth Mkm lowered their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Finally, Roth Capital upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a report on Tuesday, July 2nd.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several institutional investors and hedge funds have recently modified their holdings of BIOX. Cape Investment Advisory Inc. acquired a new stake in shares of Bioceres Crop Solutions in the 4th quarter valued at $33,000. Wellington Management Group LLP lifted its stake in shares of Bioceres Crop Solutions by 3.1% in the 4th quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock valued at $3,253,000 after purchasing an additional 7,096 shares during the last quarter. Fourth Sail Capital LP lifted its stake in shares of Bioceres Crop Solutions by 136.1% in the 1st quarter. Fourth Sail Capital LP now owns 1,627,630 shares of the company’s stock valued at $20,606,000 after purchasing an additional 938,282 shares during the last quarter. Activest Wealth Management acquired a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at $30,000. Finally, Oppenheimer & Co. Inc. acquired a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at $139,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Trading Down 1.4 %

NASDAQ BIOX opened at $8.48 on Wednesday. Bioceres Crop Solutions has a twelve month low of $8.16 and a twelve month high of $14.05. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.83 and a current ratio of 1.28. The stock has a market cap of $532.52 million, a price-to-earnings ratio of 848.00 and a beta of 0.49. The firm’s 50 day moving average price is $10.34 and its two-hundred day moving average price is $11.33.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The firm had revenue of $124.30 million for the quarter, compared to analysts’ expectations of $126.75 million. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. Equities analysts anticipate that Bioceres Crop Solutions will post 0.81 EPS for the current year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.